Friday, February 06, 2026

 

CFC replacements behind hundreds of thousands of tonnes of global ‘forever chemical’ pollution



Chemicals brought in to help protect our ozone layer have had the unintended consequences of spreading vast quantities of a potentially toxic ‘forever chemical’ around the globe, a new study shows.






Lancaster University





Chemicals brought in to help protect our ozone layer have had the unintended consequences of spreading vast quantities of a potentially toxic ‘forever chemical’ around the globe, a new study shows.

Atmospheric scientists, led by researchers at Lancaster University, have for the first time calculated that CFC replacement chemicals and anaesthetics are behind around a third of a million tonnes (335,500 tonnes) of a persistent forever chemical called trifluoroacetic acid (TFA) being deposited from the atmosphere across the Earth’s surface between the years 2000 and 2022.

And the rate of TFA entering the environment from these sources is continuing to grow as some of these CFC replacements survive for decades in our atmosphere, with peak annual TFA production from these sources estimated to be anywhere from between 2025 and 2100.

Scientists behind the new study, published in the journal Geophysical Research Letters, used ‘chemical transport’ modelling, which simulates how chemicals move about and change in the atmosphere.

Their model quantified TFA pollution created by the breakdown in the atmosphere of hydrochlorofluorocarbons (HCFCs) and hydrofluorocarbons (HFCs), which are used in refrigeration, as well as chemicals used as inhalation anaesthetics.

Although these chemicals (known as F-gases) are being phased out (following the Montreal Protocol and the later Kigali Amendment) their presence is still increasing in the atmosphere.

TFA belongs to a class of man-made chemicals called per- and polyfluorinated alkyl substances (PFAS). This group of chemicals are often known as forever chemicals because they do not break down easily and remain in the environment for a long time.

The scientific understanding of TFA is still evolving. The European Chemicals Agency classifies TFA as harmful to aquatic life. TFA has been detected in human blood and urine and the German Federal Office for Chemicals recently proposed that TFA be classified as potentially toxic to human reproduction.

Although some agencies consider that current environmental TFA is below levels that would cause harm to humans, the potentially irreversible accumulation of TFA in the environment has led for calls for it to be designated as a planetary boundary threat.

“Our study shows that CFC replacements are likely to be the dominant atmospheric source of TFA,” said Lucy Hart, PhD researcher at Lancaster University and lead author of the study. “This really highlights the broader risks that need to be considered by regulation when substituting harmful chemicals such as ozone-depleting CFCs.”

The researchers compared modelled atmospheric TFA production (from chemical breakdown) and its deposition on the Earth’s surface with observation data such as Arctic ice-cores and rainwater measurements.

The researchers provided their model with information on how much of the source gases are present in the atmosphere and where they are located using measurements from a global monitoring network. The source gases react with other atmospheric components and break down to produce TFA.

The model contains realistic weather processes calculating how it is transported and deposited. TFA can be washed out of clouds through rain or deposited directly from the air to the surface.

The modelling shows that almost all of the TFA found in the Arctic, which is far away from known emission sources, is from CFC replacement chemicals and highlights the widespread nature of TFA pollution.

“CFC replacements have long lifetimes and are able to be transported in the atmosphere from their point of emission to remote regions such as the Arctic where they can breakdown to form TFA,” said Lucy Hart. “Studies have found increasing TFA levels in remote Arctic ice-cores and our results provide the first conclusive evidence that virtually all of these deposits can be explained by these gases.”

Away from the poles, at midlatitude regions of the globe, the researchers’ modelling also supports evidence around the emergence of HFO-1234yf, which is used in car air conditioning systems, as an important, and likely growing, source of TFA from the atmosphere.

“HFOs are the latest class of synthetic refrigerants marketed as climate friendly alternatives to HFCs,” said Professor Ryan Hossaini of Lancaster University and co-author of the study. “A number of HFOs are known to be TFA-forming and the growing use of these chemicals for car air conditioning in Europe and elsewhere adds uncertainty to future levels of TFA in our environment.”

“There is a need to address environmental TFA pollution because it is widespread, highly persistent, and levels are increasing,” said Professor Hossaini.

“The rising levels of TFA from F-gases is striking. Although HFC use is gradually being phased down, this TFA source will remain with us for decades. There’s an urgent need to understand other TFA sources and to assess TFA’s environmental impacts. This requires a concerted international effort, including more extensive TFA monitoring in the UK and elsewhere,” he said.

Professor Cris Halsall, Director of the Lancaster Environment Centre and co-author, said: “We’ve generally viewed TFA as a breakdown product from the use of a few fluorinated pesticides, but it’s clear that TFA (a very persistent chemical in the environment) arises from the use and breakdown of a very wide group of organofluorine chemicals including refrigerants, solvents, pharmaceuticals and the PFAS group in general.”

Co-author Dr Stefan Reimann, whose research team in Switzerland closely monitor the atmospheric abundance TFA-forming F-gases, said: “In all regions where TFA measurements are available, a consistent picture of increasing atmospheric concentrations and deposition to Earth's surface is emerging.

“This study is outstanding, as it combines for the first time all the important sources of atmospheric TFA and has a global focus. With increasing use of HFOs, accumulation of TFA in water bodies will potentially grow and this makes long-term monitoring a necessity.”

The study involved researchers from: Lancaster University; the University of Leeds; the University of Urbino; the Commonwealth Scientific and Industrial Research Organisation, Australia; the Norwegian Institute for Air Research; the University of California San Diego; the University of Bristol; the Kyungpook National University, Korea; the Swiss Federal Laboratories for Materials Science and Technology; and the Goethe University Frankfurt.

Their findings are detailed in the paper ‘Growth in production and environmental deposition of trifluoroacetic acid due to long-lived CFC replacements and anaesthetics’.

 

Half of all men over 60 have prostate cancer – an AI diagnostic tool could identify which need followup



Not all cases of prostate cancer need followup and treatment, but determining which are serious and which are benign has been challenging.




Norwegian University of Science and Technology

Tone Frost Bathen 

image: 

Prostate cancer is the most common form of cancer among men in Western countries. The disease is naturally linked to aging. Professor Tone Frost Bathen at NTNU leads a number of research projects on prostate cancer. The samples from patients are invaluable and are stored in liquid nitrogen. 

view more 

Credit: Photo: Anne Sliper Midling / NTNU




Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumours in both the breast and prostate.

“AI tools can take over the detection of simple and clear-cut cases, allowing doctors to spend their time on more complex ones,” said Tone Frost Bathen. She is a professor at the Norwegian University of Science and Technology (NTNU) and the project manager of an AI-powered analysis tool for prostate cancer called PROVIZ.

Tests on patients at St Olavs Hospital in Trondheim indicate that the tool is very promising.

“AI can enable radiologists to determine more quickly and more accurately whether a patient needs a biopsy, and where in the prostate it should be taken from,” explained Bathen.

A recent study shows that patients trust medical test results only if an experienced doctor confirms what has been detected.

“Trust in doctors and health professionals is key for artificial intelligence to gain a place in the diagnosis of prostate cancer. Technology alone is not enough. Human contact and professional assessment remain indispensable,” said Simon A. Berger, a PhD research fellow at NTNU.

Prostate cancer is a natural part of getting older

Prostate cancer is the most common form of cancer among men in Western countries.

Examinations have detected prostate cancer in 10 per cent of 50-year-olds, 50 per cent of 60-year-olds and approximately 70 per cent of men over the age of 80.

This shows that the disease is naturally linked to ageing.

“Prostate cancer is something most men die with, not from,” added Berger.

A blood test called PSA can help detect prostate cancer. Since it has become more common for men to take this blood test, the number of new prostate cancer cases has risen sharply. There are now approximately 5000 new cases each year.

When more people are tested for something that many individuals naturally have as part of the ageing process, the next medical step after the blood test must also be carried out more often, so that doctors can obtain a broader clinical picture of its severity.

Most trust in doctors

Currently, this next step involves taking an MRI scan, which provides a detailed image of the prostate gland and the surrounding tissue. These images need to be interpreted manually by an experienced radiologist. As the number of images taken has increased sharply, this has created a need for new and more efficient ways of making diagnoses.

Through the PROVIZ project, NTNU researchers have developed an AI-powered tool that can help doctors interpret MRI images of the prostate. PROVIZ is currently available only for use as part of the ongoing research project, but efforts are underway to apply for a patent and make the tool commercially available.

For a tool like this to be efficiency-enhancing in routine hospital practice, patients must also trust the findings detected through the use of AI.

Berger interviewed 18 men who had been diagnosed with prostate cancer through the use of PROVIZ. The study shows that trust in doctors and health professionals plays a decisive role in whether patients accept AI in the health services.

“Patients trust AI in lower-risk cases such as bone fractures, but not in cases where the perceived risk is higher, such as cancer. When the perceived risk is high, we place the greatest trust in specialized doctors who can confirm what AI has found,” explained Berger.

Doctors as guarantors

In his interviews, Berger identified three different dimensions of trust.

  1. Foundational trust in the healthcare system: many patients had positive experiences from previous encounters with the healthcare system. This laid a positive foundation.
  2. Inter-personal trust in health professionals: patients trusted the doctors and their assessments. This trust was crucial for accepting AI because the doctors explained and vouched for the technology.
  3. Possible trust in AI: even though patients recognized the potential of AI, they always wanted a human assessment as well in prostate cancer diagnostics. They were concerned about accountability, professional judgement and AI’s (in)ability to see the whole clinical picture.

“The relationship between patient and doctor is still key. For AI to be accepted in clinical practice, health professionals must be active communicators and guarantors of safety. In order for doctors to serve as guarantors, they must first understand how AI arrived at its conclusions so they can verify that it has made the correct assessment. Patients accept the use of AI within a framework they already trust,” concluded Berger.

Source:

Berger SA, Håland E, Solbjør M. Patient Perspectives on Trust in Artificial Intelligence-Powered Tools in Prostate Cancer Diagnostics. Qualitative Health Research. 2025;0(0). doi:10.1177/10497323251387545

 

Pigs and grizzlies, not monkeys, hold clues to youthful human skin



Washington State University




PULLMAN, Wash. — The secret to youthful appearance and repairing scars may lie in a microscopic skin structure humans share with pigs and grizzly bears — but, surprisingly, not monkeys.

While it had been thought these ridge and valley-like skin microstructures — called rete ridges — form during fetal growth, researchers at Washington State University’s College of Veterinary Medicine found they actually develop shortly after birth and identified a key molecular signal that drives their development.

The findings, published in the journal Nature, could lead to new therapies designed to reverse or slow skin aging and improve wound and scar repair.

“These structures degrade as we age; now we know how they form and have a blueprint to guide future work on restoring them,” said Ryan Driskell, an associate professor in the College of Veterinary Medicine’s School of Molecular Biosciences and senior author on the paper. “Most scientists assumed these skin ridges formed during early embryonic development, which explains why no one really understood their origin.”

Rete ridges act like biological “Velcro,” Driskell said, anchoring the outer layer of skin, or epidermis, to the dermal layer beneath while helping to maintain elasticity and strength. As these ridges flatten with age, skin becomes thinner and more prone to sagging and damage.

Despite their importance, research has been stalled for decades by a major hurdle: the wrong animal models.

“When most people look at the skin of different animals, they see differences in fur. Rete ridges lie under the surface of skin, however, so it wasn’t until we looked closer that we discovered that animals with thicker skin, like pigs, grizzly bears and dolphins, have rete ridges like we do,” said Sean Thompson, a doctoral student in Driskell’s lab who served as first author on the study. “In contrast, common biomedical models for humans like mice and non-human primates are furry and lack rete ridges.”

While the grizzly bear provided evolutionary data that suggests body size dictates skin structure, the bear’s unique biology made it impossible to track day-by-day development of rete ridges. This led the team to the pig, which has a developmental timeline that researchers could precisely monitor.

Partnering with local farmers, the team collected skin tissue samples from pigs at various developmental stages and ultimately showed that rete ridges form after birth.

“We expected this structure to be established before birth, so seeing it emerge afterward was a surprise,” Driskell said. “That timing changes how we think skin architecture is built and why it may be possible to influence it later in life.”

Using advanced genetic mapping techniques, the team also identified a key biological pathway — bone morphogenetic protein (BMP) signaling — that activates to form these structures. This pathway serves as a set of molecular instructions, guiding how cells communicate and organize into complex tissue. Since rete ridges disappear with age, reactivating BMP signaling could help restore youthful skin and improve scar repair, in addition to possibly leading to new treatments for conditions like psoriasis.

“That BMP signaling drives rete ridges is exciting as it holds significant translational potential,” said Maksim Plikus, a professor at the University of California, Irvine and co-author on the paper. “Use of BMP proteins has already been FDA-approved for orthodontic applications, mapping the way for their use in aged skin and scars.”

The discovery also has the potential to help improve livestock health and adaptability to different climates. By understanding how these features form, researchers can explore ways to breed pigs and other livestock with skin traits suited for different conditions.

Driskell has filed a provisional patent related to his team’s discoveries.

The study involved WSU’s Bear Research, Education and Conservation Center and partnerships with local farmers and producers, with additional contributions from the University of Washington Birth Defects Research Laboratory and clinical collaborators at Spokane Dermatology. It was supported by the National Institutes of Health and the USDA Agricultural Research Service through the Resilient Livestock Initiative.